Impact of Immunosuppressants on the Therapeutic Efficacy of In Vitro-Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Allotransplantation
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference43 articles.
1. Immunosuppressive drugs and the risk of cancer after organ transplantation.;Dantal;N Engl J Med,2005
2. Both CD4+CD25+ and CD4+CD25− regulatory cells mediate dominant transplantation tolerance.;Graca;J Immunol,2002
3. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.;Hara;J Immunol,2001
4. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: Correlation with transplant outcome.;Meloni;Transplantation,2004
5. Regulatory CD25+ T cells in human kidney transplant recipients.;Salama;J Am Soc Nephrol,2003
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation;Frontiers in Immunology;2022-11-17
2. A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation;Frontiers in Pediatrics;2022-05-11
3. Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy;Clinics and Research in Hepatology and Gastroenterology;2021-09
4. The Presence of a Marked Imbalance Between Regulatory T Cells and Effector T Cells Reveals That Tolerance Mechanisms Could Be Compromised in Heart Transplant Children;Transplantation Direct;2021-04-23
5. Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients;JCI Insight;2019-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3